Compound 9a is an analogue of paprotrain that exhibited enhanced inhibition of MKLP2 ATPase and microtubule-stimulating activity and demonstrated promising cytotoxicity in human cancer cell lines [92,95]. The gene discussed is KIF20A; the disease is cancer.